Autopsy report · NCT00453817

Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Feasibility issues”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 4 months after it had already started.
Ran for about 5 years before it stopped.
5 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: University Hospital, Geneva
Sponsor type: University, hospital or other
Conditions: Type 1 Diabetes Mellitus
Interventions: ferucarbotran (iron-based MRI contrast agent); Islet transplantation; Magnetic resonance imaging
Participants: 5
Sites: 1
Countries: Switzerland

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.